15794
Coumarin 466
BioReagent, suitable for fluorescence, ≥98.0% (HPLC)
Synonym(s):
7-(Diethylamino)coumarin
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C13H15NO2
CAS Number:
Molecular Weight:
217.26
Beilstein:
3609055
EC Number:
MDL number:
UNSPSC Code:
12161900
PubChem Substance ID:
Recommended Products
product line
BioReagent
Assay
≥98.0% (HPLC)
form
solid
fluorescence
λex 380 nm; λem 460 nm in methanol
suitability
suitable for fluorescence
storage temp.
2-8°C
SMILES string
CCN(CC)c1ccc2C=CC(=O)Oc2c1
InChI
1S/C13H15NO2/c1-3-14(4-2)11-7-5-10-6-8-13(15)16-12(10)9-11/h5-9H,3-4H2,1-2H3
InChI key
QXAMGWKESXGGNV-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Doroty Codoni et al.
International journal of pharmaceutics, 496(2), 1015-1025 (2015-11-05)
Disc-shaped nanoparticles with high aspect ratios have been reported to show preferential cellular uptake in vitro by mammalian cells. However, engineering and producing such disc-shaped nanoparticles are often complex. This study reports for the first time the use of a
Pradip Nirbhavane et al.
AAPS PharmSciTech, 18(3), 829-837 (2016-06-29)
Rifabutin (RFB) is prescribed for the treatment of tuberculosis infections as well as Mycobacterium avium complex (MAC) infection in immunocompromised individuals and HIV patients. With a view to develop a sustained release oral solid lipid nanoformulation (SLN), RFB was encapsulated
Sudeep Sudesh Pukale et al.
Acta biomaterialia, 115, 393-409 (2020-08-28)
Lipid-polymer hybrid nanoparticles (LPNs) exhibit several advantages over polymeric and non-polymeric systems in terms of improved drug loading, controlled release, stability, and cellular uptake. Herein we report a scalable and stable monolithic lipid-polymer hybrid nanoparticles (LPNs) consisting of a combination
Yusuf Haggag et al.
Drug delivery and translational research, 10(5), 1353-1366 (2020-04-03)
Poly(lactic-co-glycolic acid) nanocapsules containing amphiphilic biosurfactant sophorolipids were formulated using a dispersion-based procedure. Di-block copolymers were used to vary peripheral poly(ethylene glycol) density, and variation in the oil core was used to achieve efficient encapsulation of the sophorolipid payload. Particulate
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service